FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Immunization, Realm US

19,481 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 13400 - 13600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
hl7.fhir.us.registry-protocolsR4ValueSet/DiabetesMellitusDiabetes Mellitusactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/DyslipidemiaDyslipidemiaactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HeartFailureHeart Failure codes from SNOMEDactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HypertensionHypertensionactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/PercutaneousCoronaryInterventionPCIactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/PriorCABGPrior History of Coronary Artery Bypass Graftactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HypothermiaInducedInduced Hypothermia Codesactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/OrganDonorSNOMED Valueset of Organ Donor codesactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/AbnormalElectrocardiacAssessmentAbnormal Electrocardiac Assessmentactivecic2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/benzodiazepine-medicationsBenzodiazepine medicationsactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.230All Cancer Directed therapiesactive2024-05hl7
hl7.fhir.us.registry-protocolsR4ValueSet/FamilyPrematureCADFamily History of Premature CADactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.158Multiple Myeloma Regimen Drugsactive2019-08hl7
fhir.cdc.opioid-cds-r4R4ValueSet/naloxone-medicationsNaloxone medicationsactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/cdc-malignant-cancer-conditionsCDC malignant cancer conditionsactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.226Opioids, Allactive2024-01hl7
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-analgesics-with-ambulatory-misuse-potentialOpioid analgesics with ambulatory misuse potentialactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/extended-release-opioid-with-ambulatory-misuse-potentialExtended release opioid with ambulatory misuse potentialactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1053Carbidopa Levodopa Combination (RXNORM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2362Tuberculosis (Ethambutol) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2363Tuberculosis (Isoniazid [INH]) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2364Tuberculosis (Pyrazinamide [PZA]) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2365Tuberculosis (Rifabutin) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2366Tuberculosis (Rifampin) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2367Tuberculosis (Rifapentine) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.741Hepatitis B Immune Globulin (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.747Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.844Tuberculosis (Second Line Drugs for Treatment) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.991Rifampin (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1594HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1595HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1597HIV Infection (ARV Combination Treatment for HIV) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1598HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1600HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1634Sofosbuvir Velpatasvir Combination (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1912Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1913Penicillin G [Procaine] [Injectable] (RXNORM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1078Opioid Overdose and Poisoning (Naloxone) (RxNorm)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1618Smallpox Vaccine (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2142Linezolid (RXNORM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2143Tuberculosis (Pretomanid) (RXNORM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2144Tuberculosis (Bedaquiline) (RXNORM)active2023-01hl7
hl7.fhir.us.davinci-crdR4ValueSet/configTypesCRD Configuration Code Data Types Value Settrial-use4fm2025-08hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-high-dose-rate-technique-vsBrachytherapy High Dose Rate Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-high-dose-rate-electronic-technique-vsBrachytherapy High Dose Rate Electronic Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-low-dose-rate-temporary-technique-vsBrachytherapy Low Dose Rate Temporary Radiation Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-pulsed-dose-rate-technique-vsBrachytherapy Pulsed Dose Rate Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-permanent-seeds-technique-vsBrachytherapy Permanent Seeds Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-radiopharmaceutical-technique-vsBrachytherapy Radiopharmaceutical Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-carbon-ion-beam-technique-vsCarbon Ion Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-electron-beam-technique-vsElectron Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-neutron-beam-technique-vsNeutron Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-photon-beam-technique-vsPhoton Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-proton-beam-technique-vsProton Beam Technique Value Setactive3cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6037Industry (Census)active2012-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.16Reasons for Interventions Related to Medication Managementactive2022-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1026Pregnancy Trimesteractive2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.558Butalbital analgesicsactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.789Social Determinants of Health Proceduresactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.790Social Determinants of Health Service Requestsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.11Food Insecurity Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.118Health Literacy Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.119Health Literacy Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.122Medical Cost Burden Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.123Medical Cost Burden Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.124Health Insurance Coverage Status Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.125Health Insurance Coverage Status Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.20Homelessness Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.21Homelessness Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.226Digital Literacy Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.227Digital Literacy Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.235Digital Access Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.236Digital Access Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.247Utility Insecurity Proceduresactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.252Utility Insecurity Service Requestsactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.260Incarceration Status Proceduresactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.261Incarceration Status Service Requestsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.268Language Access Proceduresactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.269Language Access Service Requestsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.27Transportation Insecurity Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.28Transportation Insecurity Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.31Financial Insecurity Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.32Financial Insecurity Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.38Material Hardship Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.39Material Hardship Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.44Housing Instability Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.45Housing Instability Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.52Inadequate Housing Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.53Inadequate Housing Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.56Less Than High School Education Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.57Less Than High School Education Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.59Unemployment Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.60Unemployment Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.67Elder Abuse Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.68Elder Abuse Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.7Food Insecurity Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.87Stress Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.90Veteran Status Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.91Veteran Status Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.92Stress Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.94Social Connection Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.95Social Connection Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.97Intimate Partner Violence Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.98Intimate Partner Violence Service Requestsactive2024-06hl7
fhir.cdc.opioid-cds-r4R4ValueSet/amphetamines-class-medicationsAmphetamine class medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.965Amplification and Extraction Kitactive2008-01
hl7.fhir.us.covid19libraryR4ValueSet/covid-19-severity-value-setCOVID-19 Signs and Symptoms Severity Value Setactive2022-07hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-TumorMarginDescriptionVSBC TumorMarginDescriptionVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-Ki-67NuclearAntigenVSBC Ki-67NuclearAntigenVS ValueSetdraft2018-08hl7
signal.core.r4R4ValueSet/servicerequest-orderdetailService Request Order Details Codesdraft1oo2019-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7613Job Supervisory Level or Pay Grade (ODH)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7652Mailing Address Indicator (NCHS)active2017-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.22.5.306Infectious Diseaseactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3124Body Region (Tetanus)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7189Specimen Source (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7554Specimen Collection Site AST (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3285Anatomical Entity (Body Site)active2009-01
hl7.fhir.us.breastcancerR3ValueSet/cimi-element-AnatomicalDirectionVSBC AnatomicalDirectionVS ValueSetdraft2018-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1074Animalactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3072Animal Type (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7793Likely Contact (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3067Virus Variant Type (Animal Rabies)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3068Animal Species (Animal Rabies)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7971Animal Type (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7967Animal Type (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7999Animal Type (Anthrax)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.21Annual Physical CPT CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.23Annual Physical CPT for Tax Pair CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.30Annual Physical Codes for Tax Pair CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.22Annual Physical HCPCS CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.17Annual Physical ICD10 CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.16Annual Physical ICD9 CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.24Annual Physical ICD9 for Tax Pair CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.18Annual Physical SNOMED CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.19Annual Physical Taxonomy CN5active2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3125Case Classification Exposure Sourceactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8013Exposure Source (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3089Interview Statusactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3167Therapy Extended Reason (TB)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3074Case Traced to Carrieractive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3119Acute Convalescent IgG Difference (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3166Cause of Death Related to TBactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7620Antacids (FDD)active2017-01
hl7.fhir.us.breast-radiologyR4ValueSet/rde1559-depthRDE1559 Depthdraft2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3212Signs and Symptoms (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3220Disease Type (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3207Lab Test Result Name (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3216Medication Treatment (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3317Antimicrobial Susceptibility Test Method (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3316Antimicrobial Agent (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8036Antibiotic Dose Units (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7693Antibiotic Received (RIBD)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3120Antibiotic Received (Pertussis)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7619Antibiotics (FDD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7553Specimen Type AST (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7557Susceptibility Test Interpretation (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7704Susceptibility Interpretation (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7701AR Test Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7556Susceptibility Test Method (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7559Susceptibility Test Result Quantitative (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7558Susceptibility Test Result Units (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7555Susceptibility Test Type (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7700AR Agent (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8005Antimicrobials (Anthrax)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.45Endometrial Cancer ICD9active2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/conditions-documenting-substance-misuseConditions documenting substance misuseactive2025-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1045Specimen Riskactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6038Morphology of Neoplasms ICD-9-CMactive2012-01
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-brachytherapy-applicator-type-vsBrachytherapy Applicator Type Value Setactivecgp2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.2.7Nutritional Statusactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.326Arboviral Disease [Other] (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.575Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.576Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.577Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.578Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.579Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative])active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.580Arboviral Disease [Other] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.963Arboviral Disease [Other] (Disorders) (SNOMED)active2025-02hl7
hl7.fhir.us.registry-protocolsR4ValueSet/ArterialAccessSiteArterial Access Siteactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.7Common substances for allergy and intolerance documentationactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.8Common substances for allergy and intolerance documentation including refutationsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.39Personal Health Goal Options Groupingactive2025-03hl7
ca.on.dhdr.r4.v4R4ValueSet/drug-service-coverageDrug Service Coverageactivehl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.60Social History Type (SCT)active2025-04hl7
hl7.fhir.us.ndhR4ValueSet/NdhAssociatedServersTypeVSAssociated Servers Type Value Settrial-usepa2025-07hl7
hl7.fhir.us.breast-radiologyR4ValueSet/AsymmetryAbnormalityTypeVSAsymmetry Abnormality Type ValueSetactive2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7140Autopsy Planned (NCHS)active2014-01
fhir.ca-bc.clientR4ValueSet/bc-address-validation-value-setBC Address Validation Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-contact-point-system-value-setBC Contact Point System Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-contact-point-use-value-setBC Contact Point Use Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-expertise-value-setBC Expertise Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-identifier-status-value-setBC Identifier Status Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-language-value-setBC Language Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-merge-status-value-setBC Merge Status Value Setactive2025-02hl7
fhir.ca-bc.clientR4ValueSet/bc-name-use-value-setBC Name Use value set.active2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-organization-role-value-setBC Organization Role Code Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-practitioner-role-value-setBC Practitioner Role Code Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-address-validation-status-value-setBC Address Validation Status Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-communication-purpose-value-setBC Communication Purpose Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/bc-end-reason-value-setBC End Reason Value Setactive2025-02hl7